糖尿病与新冠病毒：大流行期间的糖尿病研究资金与支持。
Diabetes and Covid-19: Diabetes research funding and support during the pandemic.
机构信息
EURADIA, Chichester, UK.
Health Outcomes Insights Ltd (Formerly DHP Research), Oxfordshire, UK.
出版信息
Diabetes Res Clin Pract. 2023 Apr;198:110597. doi: 10.1016/j.diabres.2023.110597. Epub 2023 Feb 23.
AIMS
Between late 2020 and early 2022, EURADIA undertook a survey of organisations and individuals supporting or working in the field of diabetes research with the aim of understanding better the impact of the Covid-19 pandemic on funding for diabetes research in Europe.
METHODS
Information was collected via online survey augmented in some cases by face-to-face interviews.
RESULTS
Findings were mixed but the majority of those responding suggested a moderate impact of the pandemic on diabetes research activity. Many respondents reported a reduction in funding during the pandemic and many of those involved in clinical research experienced a reduction in research clinicians' availability for diabetes research as they were redeployed to Covid-19 patient care. It was frequently reported that the impact might not be fully appreciated until several years after the end of the pandemic.
CONCLUSIONS
This preliminary survey suggests there may be a significant impact of the pandemic on all aspects of diabetes research and that a more detailed follow-up on the impact of the pandemic on funding of diabetes research should be carried out in the future.
目的
在 2020 年末至 2022 年初，EURADIA 对支持或从事糖尿病研究领域的组织和个人进行了一项调查，旨在更好地了解新冠疫情对欧洲糖尿病研究资金的影响。
方法
通过在线调查收集信息，在某些情况下通过面对面访谈进行补充。
结果
调查结果喜忧参半，但大多数受访者认为疫情对糖尿病研究活动有一定的影响。许多受访者报告说，在疫情期间资金减少了，许多参与临床研究的人员因为被重新部署到新冠患者护理中，用于糖尿病研究的临床医生可利用的资源减少了。人们经常报告说，这种影响可能要在疫情结束几年后才能完全显现出来。
结论
这项初步调查表明，疫情可能对糖尿病研究的所有方面都产生重大影响，未来应该对疫情对糖尿病研究资金的影响进行更详细的跟踪调查。
Zotero 插件